Dow Jones Top Company Headlines at 11 PM ET: EverBank to Combine With WaFd to Create $75 Billion Bank | Robinhood ...
EverBank to Combine With WaFd to Create $75 Billion Bank
Florida-based EverBank Financial has reached a deal to pursue a reverse merger with the smaller bank in the Pacific Northwest.
----
Robinhood Wins a New Role in the Oura IPO: Underwriter
Playing an official part in the IPO process could give Robinhood more influence over the number of shares allocated to its customers.
----
Amazon Plane Crash Probe Examines Aircraft Speed, Runway Safeguards
The NTSB chairwoman said the Boeing jet careened 1,300 feet off the runway, hitting a van with seven people.
----
Chinese Company Draws Fire for Laying Off 100 Grads a Month After Hiring Them
The major auto parts maker landed in hot water with authorities as young people in the country face a bleak job market.
----
The World Can't Get Enough of These Japanese Sneakers
Onitsuka Tigers are having a moment as a weak yen and classic looks lure tourists to Tokyo stores.
----
A $2,000 iPhone is coming soon as Apple aims for high-end buyers
Apple's launch event on Wednesday is likely to feature the iPhone 18 and 18 Pro - as well as a foldable iPhone Ultra with a starting price near $2,000.
----
How Nvidia's Investment Juggernaut Can Jump from Big to Enormous
Nvidia has big investments in Intel, SpaceX and many more public companies. But its stakes in OpenAI and Anthropic are the real prize.
----
Volkswagen Factory to Become Defense Plant in Deal With Israel's Aurelius
Under the deal, investment company Aurelius would take over the plant as majority owner, together with the state of Lower Saxony.
----
CXMT Highlights Smartphone, AI Advances as Market Share Climbs
The Chinese memory-chip maker sought to reassure investors that it is gaining ground in higher-end memory markets, citing advances in smartphone and artificial-intelligence technologies.
----
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
The Danish drugmaker said the clinical trial met its primary goal after 68 weeks of treatment.
----
Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial
The company said the late-stage study for its pelacarsen drug missed its primary objective of reducing the risk of cardiovascular events like death, heart attack and stroke compared with placebo.
(END) Dow Jones Newswires
September 07, 2026 23:15 ET (03:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The Smartest Moves for Bond Investors Today, and What to Do When You Have Too Many Investments
Undervalued by 15%, This Utilities Stock Could Be an Unexpected AI Winner
The Thrilling 37
The 10 Best and 10 Worst Months of All Time for the US Stock Market
United States